If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open itKidney transplant recipients are predisposed to new-onset diabetes after transplantation (often referred to as NODAT). Medications that promote development of NODAT include glucocorticoids, tacrolimus, and the mammalian target of rapamyciOriginal toplevel document (pdf)
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p3418